Emtricitabine, Tenofovir Disoproxil Fumarate

3 trials JAnti-infectives

Filter these 3 trials by condition, phase, country and more.

Open in Search →

3 Registered trials

0 Recruiting

3 Completed trials

2 Sponsors

5 Countries

Phase III

Phase II/III

Phase IV

Phase III: 1 Phase II/III: 1 Phase IV: 1

Sponsors using this IMP

Gilead Sciences Inc. 2 Fundacion Seimc Gesida 1

All trials

3 total

Study to Compare an Oral Weekly Islatravir/Lenacapavir Regimen With Standard of Care in Virologically Suppressed People With HIV-1 ( ISLEND-… Ended

2024-514047-28-00 Phase III 4 countries Gilead Sciences Inc.
Study of Lenacapavir Taken Twice a Year for HIV Pre-Exposure Prophylaxis (PrEP) Ended

2023-507891-31-00 Phase II/III 1 country Gilead Sciences Inc.
Phase IV comparative, randomized, open-label pilot study to evaluate the efficacy and safety of a rilpivirine-based antiretroviral treatment… Ended

2022-503110-23-00 Phase IV 1 country Fundacion Seimc Gesida

Showing 1–3 of 3 trials

← All drugs A–Z